JANUX THERAPEUTICS
(NASDAQ: JANX)
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.
54.390
+0.400
(+0.74%)
Range
52.679 - 55.930
(6.17%)
Open
54.280
Previous Close
53.990
Bid Price
13.700
Bid Volume
9
Ask Price
15.420
Ask Volume
8
Volume
542,699
Value
-
Remark
Delayed prices. Updated at 02 Nov 2024 04:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
